Treatment Options for Bladder Pain Syndrome

Diagnosis and Initial Assessment

IC/BPS is defined as an unpleasant sensation perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than six weeks duration, in the absence of infection or other identifiable causes 3
Cystoscopy should be performed in patients suspected of having Hunner lesions, as this finding significantly impacts treatment approach 4
Baseline voiding symptoms and pain levels should be documented using validated tools such as the genitourinary pain index (GUPI), interstitial cystitis symptom index (ICSI), or visual analog scale (VAS) to measure treatment effects 5

Patient education about normal bladder function, the chronic nature of IC/BPS, and the need for potentially multiple treatment trials is essential 5
Altering urine concentration through fluid management may improve symptoms 6
Application of local heat or cold over the bladder or perineum may improve symptoms 6
Stress management techniques and relaxation strategies may improve symptoms 5
Pelvic floor muscle relaxation and bladder training with urge suppression may improve symptoms 6

Amitriptyline is recommended as one of the most effective oral medications for IC/BPS 6
Cimetidine may be considered as an oral medication option for IC/BPS 6
Hydroxyzine may be considered as an oral medication option for IC/BPS 6

Heparin instillations may be considered as an intravesical treatment option for IC/BPS 6
Lidocaine instillations may be considered as an intravesical treatment option for IC/BPS 6

For patients with Hunner lesions, fulguration and/or injection of triamcinolone should be performed 7
Cystoscopy with hydrodistension may serve both diagnostic and therapeutic purposes 6
Neuromodulation may be considered for patients who fail conservative treatments 8

Surgical interventions such as urinary diversion with or without cystectomy should be reserved for patients with severe, unremitting symptoms that have failed all other treatment options 8
For patients with end-stage structurally small bladders, diversion may be indicated at any time the clinician and patient believe appropriate 3

The American Urological Association guideline recommends a stepped approach to treatment, starting with behavioral modifications and patient education, then adding oral medications, intravesical treatments, and procedures as needed 2
The treatment approach should be tailored to specific patient characteristics rather than following a rigid tiered approach 2

Pain management should be continually assessed and addressed throughout treatment using multimodal approaches 4
Ineffective treatments should be discontinued after an appropriate trial period 4
Patients should be informed that IC/BPS is typically a chronic condition requiring ongoing management with periods of symptom exacerbation and remission 5